OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
12
Results
Show all
Save search
Copy query
Show results for
Unknown
(12)
Publication Date
Release Date
2025
(4)
2023
(3)
2024
(2)
2021
(2)
2022
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
METTL4-mediated nuclear N6-deoxyadenosine methylation promotes metastasis through activating multiple metastasis-inducing targets.
Not available
S-EPMC9716733
|
biostudies-literature
Cite
Phase I study of oral metronomic gemcitabine (D07001) in patients with advanced solid tumors.
Not available
S-EPMC12012807
|
biostudies-literature
Cite
Comparison of the Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Patients on Hemodialysis with Secondary Hyperparathyroidism.
Not available
S-EPMC10658267
|
biostudies-literature
Cite
Global Impact of COVID-19 on Stroke Care and IV Thrombolysis.
Not available
S-EPMC8205458
|
biostudies-literature
Cite
Characterizing Long COVID Symptoms During Early Childhood.
Not available
S-EPMC12117493
|
biostudies-literature
Cite
Characterizing Long COVID in Children and Adolescents.
Not available
S-EPMC11339705
|
biostudies-literature
Cite
Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Not available
S-EPMC10949203
|
biostudies-literature
Cite
Mapping the human genetic architecture of COVID-19.
Not available
S-EPMC8674144
|
biostudies-literature
Cite
A second update on mapping the human genetic architecture of COVID-19.
Not available
S-EPMC10482689
|
biostudies-literature
Cite
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Not available
S-EPMC12303861
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets